Pharma's Almanac

4843 Articles Available

1 202

M&A

Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization

PR-M04-21-016

Microsoft Accelerates Industry Cloud Strategy for Healthcare with the Acquisition of Nuance

PR-M04-21-013

Partnership

BioVectra and PhaseBio Discuss Creating an Optimal Partnership

PTV-04-21-CL-001

Construction

How Agile Construction Practices Can Help Bring New Drugs and Vaccines to Market

PAO-04-21-CL-05

M&A

Sanofi Acquires Tidal Therapeutics and Adds an mRNA-Based Research Platform

PR-M04-21-012

COVID-19

Lilly Modified COVID-19 Purchase Agreement for Bamlanivimab and Etesevimab Together

PR-M04-21-010

Manufacturing

Sanofi to Invest in Vaccine Production Site in Singapore

PR-M04-21-011

Diagnostics

LumiraDx, a Next-Generation Point of Care Diagnostics Testing Company to List on Nasdaq via Merger with CA Healthcare Acquisition Corp

PR-M04-21-009

Blockchain

Using Blockchain to Drive Drug Development and Healthcare Data Management

PAO-04-21-NI-01

Amneal Completes Acquisition of Kashiv Specialty Pharmaceuticals

FDA Approval

FDA Approves Trodelvy®, the First Treatment for Metastatic Triple-Negative Breast Cancer Shown to Improve Progression-Free Survival and Overall Survival

PR-M04-21-007

Cell and Gene Therapy Clinical Trials

Minimizing Patient Burden in Cell and Gene Therapy Trials

PAO-04-21-CL-03

Direct-to-Patient

Supporting Global Decentralized and Virtual Clinical Trials During Challenging Times and Beyond

PAO-03-21-CL-05

Vaccine

Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001

PR-M04-21-006

Pharma Equipment

Distek, Inc. Releases BIOne 1250 Dual Bioprocess Control Station

PR-M04-21-004

Oncology Clinical Trials

Accelerating Oncology Clinical Research Remotely

PAO-04-21-CL-02

Used Equipment

PharmParts - This Makes Sense! 5 Reasons To Consider Purchasing Secondhand Parts

PAO-04-21-CL-01

Clinical Trials

Lilly, Vir Biotechnology and GSK Announce Positive Topline Data From the Phase 2 Blaze-4 Trial Evaluating Bamlanivimab With Vir-7831 in Low-risk Adults With Covid-19

PR-M04-21-004

FDA Approval

United Therapeutics Announces FDA Approval and Launch of Tyvaso for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

PR-M04-21-003

GSK to Support Manufacture of Novavax’ COVID-19 Vaccine

PR-M04-21-002

Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics

PR-M04-21-001

Piramal Pharma Ltd. To Acquire 100% Stake in Hemmo Pharmaceuticals, a Leading Indian Manufacturer of Peptide APIs

PR-M03-21-008

Medical Device

BrainScope Launches Next-Gen Medical Device for Concussion Detection

PR-M03-21-007

Celonic and CureVac Announce Agreement to Manufacture over 100 Million Doses of CureVac’s COVID-19 Vaccine Candidate, CVnCoV

PR-M03-21-006

1 202

»